Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Deals

Biotech’s trend of commercial stage M&A continues with Alcon takeout of Aerie

Deal values Aerie at $770M with a 37% premium

By Stephen Hansen, Associate Editor
August 23, 2022 5:28 PM UTC

Biotech continued its M&A momentum for commercial-stage companies on Tuesday, as Alcon agreed to acquire Aerie Pharmaceuticals for $770 million.

The deal marks the seventh biopharma takeout in 3Q22 with a minimum value of at least $200 million and gives Alcon Inc. (SIX:ALC; NYSE:ALC) two marketed ophthalmic therapies: Rhopressa netarsudil and Rocklatan netarsudil/latanoprost. ...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Aerie Pharmaceuticals Inc.

Alcon Inc.